Arcinova is a Contract Research and Development Organisation (CRDO), providing a comprehensive range of integrated specialist services, spearheading the use of new technology processes to support the development of pioneering drugs for the treatment of life-threatening illnesses.
This is an exciting time for Arcinova. We have a fantastic team, a world-class facility and strong market opportunity. We selected BGF because of its long-term approach to investing, and its ability to provide additional funding as we embark on a period of capital expenditure and international expansion.Professor Ian Shott, executive chair
Business funding insights
A decade of hard work coming to fruition? Just look at our investments and exits
Far from slowing down as a result of the coronavirus pandemic, BGF’s investment activity has stepped up both in pace and volume.
Exit strategies: how to get the timing and valuation right
More than 100 BGF-backed businesses have achieved exits. Our panel of experts discuss the exit strategies that are proven to succeed.